Search results
Results From The WOW.Com Content Network
780.8 Sweating, excessive; 780.9 Other general symptoms. 780.91 Fussy infant; 780.92 Crying, infant, excessive; 780.93 Memory loss; 780.94 Early satiety; 780.95 Other excessive crying; 780.96 Generalized pain; 780.97 Altered mental status; 780.99 Other general symptoms; 781 Symptoms involving nervous and musculoskeletal systems. 781.0 Abnormal ...
Symptoms of hypoventilation and breathing malfunctions typically present after the rapid weight gain. Some patients may initially develop obstructive sleep apnea, which is common in obese children. [3] Obstructive sleep apnea is the most common form of sleep apnea, and causes breathing to abruptly stop and begin again during sleep.
The most effective treatment is weight loss, but this may require bariatric surgery to achieve. [3] Weight loss of 25 to 30% is usually required to resolve the disorder. [3] The other first-line treatment is non-invasive positive airway pressure (PAP), usually in the form of continuous positive airway pressure (CPAP) at night.
Central hypoventilation syndrome (CHS) is a sleep-related breathing disorder that causes ineffective breathing, apnea, or respiratory arrest during sleep (and during wakefulness in severe cases). CHS can either be congenital (CCHS) or acquired (ACHS) later in life.
The terms obstructive sleep apnea syndrome (OSAS) or obstructive sleep apnea–hypopnea syndrome (OSAHS) may be used to refer to OSA when it is associated with symptoms during the daytime (e.g. excessive daytime sleepiness, decreased cognitive function). [2] [3]
The typical screening process for sleep apnea involves asking patients about common symptoms such as snoring, witnessed pauses in breathing during sleep and excessive daytime sleepiness. [19] There is a wide range in presenting symptoms in patients with sleep apnea, from being asymptomatic to falling asleep while driving. [19]
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
Sleep apnea is measured by the apnea-hypopnea index (AHI). An AHI is determined with a sleep study. AHI values for adults are categorized as: [2] [3] Normal: AHI<5; Mild sleep apnea: 5≤AHI<15; Moderate sleep apnea: 15≤AHI<30; Severe sleep apnea: AHI≥30; An episode is when a person hesitates to breathe or stops their breathing altogether.